US 2020/0264161 A1 · CANCER RISK EVALUATION METHOD AND CANCER RISK EVALUATION SYSTEM

Abstract

A cancer risk evaluation method is provided, which makes it possible to estimate the risk of suffering from cancer of a subject with high accuracy, which do not have the disadvantages of early degeneration and high cost that arise in the case where the in-blood amino acid concentrations are utilized, and which are capable of estimating which site of cancer a subject has. This method includes the step S1 of measuring the concentrations of a set of evaluation elements contained in a serum sample 2 taken from a subject, the step S2 of applying concentration data of the set of elements thus measured and age data of the subject to a discriminant function or functions for discriminating to which of a case group and a control group the subject belongs to perform an operation; and the step S3 of obtaining an indicator for discriminating whether or not the subject suffers from any type of cancer based on a correlation among the set of evaluation elements obtained in the step S2. As the set of evaluation elements, a combination of 17 elements of Na, Mg, P, S, K, Ca, Fe, Cu, Zn, Se, Rb, Sr, As, Mo, Cs, Co, and Ag is used.

Claims14

Dependent claims

A cancer risk evaluation method comprising:

the correlation operating step of operating a correlation among concentrations of a set of evaluation elements contained in a serum which is taken from a subject by applying concentration data of the set of evaluation elements and age data of the subject to a discriminant function or functions for discriminating which of a case group and a control group the subject belongs to;
and
the indicator obtaining step of obtaining an indicator for discriminating whether or not the subject suffers from any type of cancer based on the correlation operated in the correlation operating step;
wherein in the correlation operating step, a combination of 17 elements of Na, Mg, P, S, K, Ca, Fe, Cu, Zn, Se, Rb, Sr, As, Mo, Cs, Co, and Ag is used as the set of evaluation elements;
and
in the indicator obtaining step, the indicator is generated based on a discriminant score or scores calculated by applying the concentration data and the age data to the discriminant function or functions which is/are used in the correlation operating step.

3 more elements

A cancer risk evaluation system comprising:

a data storage section for storing concentration data of a set of evaluation elements contained in a serum which is taken from a subject and age data of the subject;
a discriminant function generation section for generating a discriminant function or functions for discriminating which of a case group and a control group the subject belongs to;
and
an evaluation result operation section for operating a correlation among concentrations of the set of evaluation elements contained in the serum by applying the concentration data of the subject and the age data thereof stored in the data storage section to a discriminant function or functions generated by the discriminant function generation section, thereby outputting an evaluation result that discriminates whether or not the subject suffers from any type of cancer based on the correlation;
wherein a combination of 17 elements of Na, Mg, P, S, K, Ca, Fe, Cu, Zn, Se, Rb, Sr, As, Mo, Cs, Co, and Ag is used as the set of evaluation elements;
and
in the evaluation result operation section, a discriminant score or scores is/are calculated by applying the concentration data and the age data which are stored in the data storage section to the discriminant function or functions which is/are generated by the discriminant function generation section, and the evaluation result is generated based on the discriminant scores.

4 more elements

Dependencies are inferred from the claim text.

Cancer risk evaluation method and cancer risk evaluation system

Life of this patent

Cancer risk evaluation method and cancer risk evaluation system

Life of this patent

Abstract

Claims14